{"article_title": "SK Capital Grabs Stake in Halo Pharmaceutical", "article_keywords": ["pharmaceutical", "stake", "grabs", "focus", "sk", "provides", "capital", "services", "manufacturing", "halo", "outsourced"], "article_url": "http://www.themiddlemarket.com/news/healthcare/sk-capital-grabs-stake-in-halo-pharmaceutical-254145-1.html", "article_text": "SK Capital Grabs Stake in Halo Pharmaceutical\n\nThe target provides outsourced pharmaceutical manufacturing services, which pharma companies often rely on so they can focus on drug development\n\nSK Capital Partners has acquired a majority stake in Halo Pharmaceutical for an undisclosed amount.\n\nHalo, headquartered in Whippany, New Jersey, provides outsourced development and manufacturing services to the pharmaceutical industry. The company makes solid, semi-solid and liquid medicines, with a particular focus on controlled substances.\n\nSK Capital, a New York private equity firm, expects the investment to help Halo grow organically and through acquisitions. The firm closed a $1 billion fund in December. Before that, in October, SK portfolio company Anchroma agreed to buy the textile operations of BASF SE (FRA: BAS).\n\nMany pharmaceutical companies have looked to outsource manufacturing as they focus more on drug development. For more on pharmaceutical manufacturing, see Pursuing Pharmaceutical Manufacturing.\n\nFor more information on related topics, visit the following:", "article_metadata": {"og": {"url": "http://www.themiddlemarket.com/news/healthcare/sk-capital-grabs-stake-in-halo-pharmaceutical-254145-1.html", "image": "http://cdn.themiddlemarket.com/media/newspics/pill-image.jpg", "site_name": "Mergers & Acquisitions, Latest News", "title": "SK Capital Grabs Stake in Halo Pharmaceutical"}}, "_id": "\"57477af46914bd0286fe0bda\"", "article_summary": "SK Capital Grabs Stake in Halo PharmaceuticalThe target provides outsourced pharmaceutical manufacturing services, which pharma companies often rely on so they can focus on drug developmentSK Capital Partners has acquired a majority stake in Halo Pharmaceutical for an undisclosed amount.\nFor more on pharmaceutical manufacturing, see Pursuing Pharmaceutical Manufacturing.\nSK Capital, a New York private equity firm, expects the investment to help Halo grow organically and through acquisitions.\nHalo, headquartered in Whippany, New Jersey, provides outsourced development and manufacturing services to the pharmaceutical industry.\nMany pharmaceutical companies have looked to outsource manufacturing as they focus more on drug development."}